Davion Healthcare Plc. (NASDAQ:DAVI – Get Free Report) was the target of a large growth in short interest in October. As of October 30th, there was short interest totaling 617,708 shares. Currently, 2.5% of the shares of the stock are short sold. Based on an average trading volume of 1,928,918 shares, the days-to-cover ratio is currently 0.3 days.
Davion Healthcare Trading Down 16.0%
Shares of Davion Healthcare stock traded down $0.19 on Friday, hitting $1.00. The company’s stock had a trading volume of 312,919 shares, compared to its average volume of 1,511,411. Davion Healthcare has a 52-week low of $0.91 and a 52-week high of $12.30.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen upgraded Davion Healthcare to a “hold” rating in a report on Saturday, October 31st.
View Our Latest Report on DAVI
Davion Healthcare Company Profile
Davion Healthcare Plc is a digital healthcare company developing proprietary, non-invasive health monitoring technologies designed to support the early identification of medical anomalies outside traditional clinical environments. The Company’s flagship product, BreastCheck, is an FDA-registered at-home breast health screening test designed to identify potential abnormalities through changes in breast temperature. Davion Healthcare Plc is based in DUBLIN.
Further Reading
- Five stocks we like better than Davion Healthcare
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Davion Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davion Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
